Scinai Immunotherapeutics Regains Nasdaq Compliance
Nasdaq confirms compliance with Listing Rule 5550(a)(2) after 19 consecutive business days with a closing bid price at or above $1.00; minimum bid price matter is closedJERUSALEM, Sept. 21, 2026 /PRNewswire/ -- Scinai